癌症易感综合征的筛查
本文综述儿童癌症易感综合征的监测影像学,重点讨论全身MRI监测的获益与风险、减少假阴性和管理假阳性的策略、标准化术语对风险分层的价值以及及时沟通结果的重要性。强调监测影像需与影像外筛查要素整合,并建立正式框架以提升诊断效能和患者体验。
要点
- 儿童癌症易感综合征需定期监测,影像筛查需权衡获益与风险。
- 全身MRI是监测影像的核心手段,需管理假阴性与假阳性结果。
- 标准化术语和及时沟通有助于风险分层和减少焦虑。
核心结论
- 癌症易感综合征筛查是多模态、多学科和纵向过程,建立正式监测影像框架可提升诊断效能并改善患者体验。
研究设计与样本
- 综述,讨论儿童癌症易感综合征监测影像的获益与风险,并整合影像与非影像筛查要素。
临床应用与阅片要点
- 阅片时应重视全身MRI监测,采用策略减少假阴性并管理假阳性结果。
- 报告中使用标准化术语进行风险分层,以更好指导患者管理。
- 需及时沟通影像结果以缓解患者及家属焦虑。
局限性
- 许多癌症易感综合征外显率不一,筛查获益与风险的权衡复杂。
- 综述未提供具体监测影像方案的量化数据或统一标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pediatric patients with cancer predisposition syndromes are at increased risk of developing malignancies compared with their age-matched peers, necessitating regular surveillance. Screening protocols differ among syndromes and are composed of a number of elements, imaging being one. Surveillance can be initiated in infants, children and adolescents with a tumor known or suspected of being related to a cancer predisposition syndrome or where genetic testing identifies a germline pathogenic gene variant in an asymptomatic child. Pre-symptomatic detection of malignant neoplasms offers potential to improve treatment options and survival outcomes, but the benefits and risks of screening need to be weighed, particularly with variable penetrance in many cancer predisposition syndromes. In this review we discuss the benefits and risks of surveillance imaging and the importance of integrating imaging and non-imaging screening elements. We explore the principles of surveillance imaging with particular reference to whole-body MRI, considering the strategies to minimize false-negative and manage false-positive whole-body MRI results, the value of standardized nomenclature when reporting risk stratification to better guide patient management, and the need for timely communication of results to allay anxiety. Cancer predisposition syndrome screening is a multimodality, multidisciplinary and longitudinal process, so developing formalized frameworks for surveillance imaging programs should enhance diagnostic performance while improving the patient experience.
引用
- Al-Sarhani H, Gottumukkala RV, Grasparil ADS, et al. Screening of cancer predisposition syndromes. Pediatr Radiol. 2021. PMID: 33791839. doi:10.1007/s00247-021-05023-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。